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There is an urgent need of biosynthetic bone grafts with enhanced osteogenic capacity. In 
this study, we describe the design of hierarchical meso-macroporous 3D-scaffolds based on 
mesoporous bioactive glasses (MBGs), enriched with the peptide osteostatin and Zn
2+
 ions, 
and their osteogenic effect on human mesenchymal stem cells (hMSCs) as a preclinical 
strategy in bone regeneration. The MBG compositions investigated were 80%SiO2–
15%CaO–5%P2O5 (in mol-%) Blank (BL), and two analogous glasses containing 4% ZnO 
(4ZN) and 5% ZnO (5ZN). By using additive fabrication techniques, scaffolds exhibiting 
hierarchical porosity: mesopores (around 4 nm), macropores (1-600 m) and big channels ( 
1000 m), were prepared. These MBG scaffolds with or without osteostatin were evaluated 
in cell cultures of hMSCs. Zinc promoted hMSCs colonization (both the surface and inside) 
of MBG scaffolds. Moreover, Zn
2+
 ions and osteostatin together, but not independently, in 
the scaffolds were found to induce the osteoblast differentiation genes runt related 
transcription factor-2 (RUNX2) and alkaline phosphatase (ALP) in hMSCs after 7 d of 
culture in the absence of an osteogenic differentiation-promoting medium. These results add 
credence to the combined use of zinc and osteostatin as an effective strategy for bone 
regeneration applications. 
 





 Bone tissue regenerates spontaneously after damage. However, in certain 
physiological situations or upon extensive damage, normal regeneration mechanisms 
are not enough to regenerate bone. In those cases, bone regeneration needs to be 
enhanced by different maneuvers such as tissue engineering approaches [1,2]. Recently, 
SiO2–CaO–P2O5 mesoporous bioactive glasses (MBGs) gained much interest for their 
excellent properties: bone regenerative capacity; high ordered mesoporous structure 
enabling them to host and release bone promoting agents [3,4]; and huge surface area 
and pore volume which provide fast in vitro responses [5,6]. The regenerative potential 
of bioactive glasses depends in part on their ionic dissolution products (Si, Ca, P) [7]. In 
addition, the bioactive properties of MBGs can be improved by including additional 












 into their structure. This 
strategy has attracted much attention by its simplicity, good stability and clinical safety 
for the proper range for each metallic ion. It has been demonstrated, both in vitro and in 
vivo, that dissolution of these metal-enriched bioactive glasses induced an increased 
intracellular ion concentration and subsequent activation of intracellular signaling 
pathways; this leads to an increased gene expression in osteoprogenitor cells which 
promotes bone regeneration [8,9]. Zinc
 
ions appear to be a good option for that purpose 
due to their capacity to increase osteogenesis [1,10] angiogenesis [11], and 
antimicrobial properties [12,13].  
 The high surface area and pore volume of MBGs are suitable to host biologically 
active molecules that, combined with their interconnected macropores and channels 
(100–1000 m), allows tissue ingrowth and vascularization [14]. In this context, rapid 
prototyping processing has been shown to be a successful technique of 
stereolithography for obtaining meso-macroporous bioactive scaffolds. Moreover, 
coating these scaffold systems with biodegradable and biocompatible biopolymers 
improves their handling and in vivo performance in terms of adsorption or release of 
ions in the surrounding medium while preserving their morphology and integrity [15]. 
Gelatin is a noncytotoxic FDA-approved biopolymer that can be formulated as a 
hydrogel with high swelling ability by crosslinking with glutaraldehyde (GA) [15]. This 
formulation appears to be an ideal bone filling agent for its flexibility and capacity to 
exert pressure in contact with body fluids, and easy surgical handling [16]. 
  
 The bioactivity of these scaffolds could also be further improved by loading 
different osteogenic molecules. In this regard, parathyroid hormone (PTH)-related 
protein (PTHrP) is an emerging bone regenerating agent whose N-terminal region is 
homologous to PTH, whereas its PTH-unrelated C-terminal region includes a highly 
conserved 107-111 sequence (named osteostatin). When intermittently administered, N-
terminal PTHrP analogues have been shown to induce bone anabolism in rodents and 
humans [17,18]. On the other hand, C-terminal PTHrP peptides exhibit antiresorptive 
properties [19], but they also have osteogenic activity in different in vitro and in vivo 
scenarios [20,23]. Very recently, our group reported a straightforward method to 
synthesize MBG disks enriched with zinc and osteostatin, exhibiting an improved 
capacity to stimulate osteoblastic cell growth and function [24].  
 In the present study, we aimed to explore the hypothesis that the combination of 
zinc-enriched MBGs and osteostatin is an interesting approach for bone tissue 
engineering. Thus, hierarchical meso-macroporous MBG scaffolds were synthesized 
based on 80% SiO2–15%CaO–5%P2O5 (mol-%) system: Blank as a control (BL), and 
including 4% or 5% of ZnO (4ZN and 5ZN), coated with GA crosslinked gelatin, and 
loaded (or not) with osteostatin. We used human mesenchymal stem cells (hMSCs) to 
decorate these scaffolds. The putative advantage of including zinc and osteostatin 
together in these MBG scaffolds to enhance cell growth and osteogenic differentiation 
of hMSCs was evaluated. 
 
2. Materials and methods 
 MBGs were synthesized by the evaporation induced self-assembly (EISA) 
technique, and MBG scaffolds as 3D structures were obtained by rapid prototyping 
techniques. They were characterized physico-chemically, and their swelling capacity 
and ion release time course were also assayed. These scaffolds were thereafter seeded 
with human mesenchymal stem cells followed by evaluation of cell toxicity and cell 
proliferation as well as osteogenic differentiation as described below. 
2.1 Synthesis of bioactive mesoporous glasses (MBGs) 
 Mesopororous glasses (SiO2CaOP2O5) were synthesized using the EISA 
(evaporation induced self-assembly) method. SiO2, P2O5 and CaO sources came from 
tetraethylorthosilicate (TEOS), triethyl phosphate (TEP) and calcium nitrate 
  
(Ca(NO3)2.4H2O) respectively, and Pluronic
®
 P123 was used as a structure directing 
agent. All of them purchased from Sigma-Aldrich (St. Louis, USA). The reaction was 
initiated with a mixture of 4.5 g of Pluronic
®
 P123 dissolved in 67.5 mL of absolute 
ethanol (EtOH) (Panreac Química SLU; Castellar del Vallés, Barcelona, Spain) and 
1.12 mL of 0.5N HNO3. One h later, 8.90 mL of TEOS were added, and 0.71 mL of 
TEP and 1.10 g of Ca(NO3)2.4H2O were subsequently incorporated every 3 h thereafter. 
The reaction was carried out overnight, but 0.60 g (4ZN) or 0.75 g (5ZN) of 
Zn(NO3)2.6H2O was added after 1 h of reaction to obtain zinc doped scaffolds (Table 1). 
Twenty four h later, the resulting sols were placed on 9-cm Petri dishes to continue with 
the EISA method. The gelation process was carried out for 4 d at 30 ºC, and the 
resulting homogeneous and transparent membranes were calcined at 700 ºC for 6 h to 
obtain the glasses.  
2.2 Fabrication of MBG scaffolds by rapid prototyping 
The so-obtained glasses were gently grinded in a mortar and sieved through a 40 
m mesh to get the glass powders. Then, 4.5 g of MBG powder was dispersed in 37 mL 
of dichloromethane (DCM), followed by addition of 2.5 g of -polycaprolactone (PCL) 
(Mw = 58,000 Da) (Sigma-Aldrich) in 25 mL of DCM. The mixture was stirred at room 
temperature until cementing with the right consistency for handling in a 3D printer rapid 
prototyping equipment 3D Bioplotter™ (EnvisionTEC, Gladbeck, Germany) printer. 
Thus, the paste was placed in a polyethylene cartridge with a 0.55-mm dispensing tip, 
setting the rod spacing to 1.5 mm. Each consecutive layer was correspondingly rotated 
to a 45º angle to generate two types of rhombohedral channels. The tip speed was set at 
300 or 50 mm/min in the horizontal or the vertical plane, respectively. The dimensions 
of the obtained cylindrical scaffolds were 6 mm diameter x 10 mm height. The scaffolds 
were dried at 37 ºC for 24 h to evaporate DCM and then treated at 700 ºC for 6 h to 
remove PCL. For some characterization techniques, such as nitrogen adsorption and 
mercury porosimetry, smaller scaffolds (6 mm diameter x 5 mm height) were generated. 
The resulting scaffolds were coated with glutaraldehyde (GA) crosslinked gelatin (2.4 
wt-%) to improve their mechanical properties (BL-GE, 4ZN-GE and 5ZN-GE 
scaffolds). Thermogravimetric analysis (TGA) was carried out in a Perkin-Elmer Pyris 
Diamond TG/DTA instrument (Waltham, MA, USA) to determine any residual content 
of PCL in the scaffolds. TGA was performed between 30 and 900 °C in air at a flow 
  
rate of 100 mL/min and a heating rate of 10 °C/min. Some of these scaffolds were 
loaded with osteostatin as described in section 2.6. (BL-GE+OST, 4ZN-GE+OST and 
5ZN-GE+OST scaffolds). 
2.3 Meso-macroporous 3D scaffolds characterization 
 Nitrogen adsorption measurements were carried out in the calcined, GA 
crosslinked gelatin coated and loaded with osteostatin scaffolds to quantify pore 
diameter, pore volume and surface area. Analyses were performed at –196 °C using a 
Micromeritics ASAP 2020 (Micromeritics, Norcross, USA).  First, 100–150 mg of each 
scaffold was degassed for 24 h at 200 °C under vacuum (< 0.3 kPa). The surface area 
(SBET) was determined by the Brunauer–Emmett–Teller (BET) technique. The total pore 
volume (VT) was calculated from the amount of N2 adsorbed at a relative pressure of 
0.97. The possible existence of micropores (< 2 nm) was analyzed by the t-plot method. 
The average mesopore diameter was determined from the adsorption branch of the 
isotherm by the Barrett–Joyner–Halenda (BJH) method. The presence of an ordered 
mesoporous arrangement was investigated by small angle X-ray diffraction (SA-XRD) 
in a Philips X’Pert diffractometer (Eindhoven, The Netherlands) equipped with a 
Cu Kα radiation source (wavelength 1.5418 Å). SA-XRD patterns were registered in the 
2θ range between 0.6° and 8°, with a step size of 0.02° and a counting time of 0.5 s per 
step. Mesoporous channel arrangement was also evaluated by transmission electron 
microscopy (TEM) of crushed scaffolds carried out in a JEOL2100 electron microscope 
operating at 200 kV (Tokyo, Japan). Fourier transform infrared FTIR spectroscopy was 
used to assess the composition of the coated and not coated scaffolds with GA 
crosslinked gelatin. The latter measurements were performed in a Thermo Scientific 
Nicolet iS10 apparatus (Waltham, MA, USA) equipped with a SMART Golden Gate
®
 
attenuated total reflection ATR, a diffuse reflectance accessory.  
To study the interconnected macroporosity of MBG scaffolds and its chemical 
composition, a JEOL JSM-6400 scanning electron microscope (SEM) (Tokyo, Japan) 
operating at 20 kV and equipped with an Oxford Instruments INCA Energy Dispersive 
X-ray (EDX) spectrometer was used. SEM micrographs from the intact scaffold surface 
and from a scaffold fracture were obtained to describe the morphology of the calcined 
scaffolds and also of those coated with GA crosslinked with gelatin. The organic matter 
content was quantified by TGA. In addition, smaller scaffolds (6 mm x 5 mm) with a 
weight of 100–150 mg were studied by mercury intrusion porosimetry as 
  
complementary information about their pore diameter and surface area. This analysis 
was done with a Micromeritics Autopore IV 9500 device (Norcross, GA, USA).  
 Nuclear magnetic resonance (NMR) was performed to study the atomic 
environments of silicon and phosphorus atoms in the tested materials. A Bruker Avance 
AW-400WB spectrometer (Karlsruhe, Germany) was used. Samples were spun at 10 




P setting the spectrometer frequencies to 79.5 and 162.0 MHz. 






2.4 Swelling assay 
 The swelling behavior of BL-GE, 4ZN-GE and 5ZN-GE scaffolds in distilled 
water at 37 ºC was determined by gravimetric analyses (%WREHYDRATION) as follows: 
 %WREHYDRATION = 100 × (Wt – Wd / Wd)            (Eq. 1)  
Where Wt is the weight of the rehydrated sample at time t, and Wd, the weight of the 
dried sample. Wt values were determined at different times until the scaffolds reached 
the swelling ratio equilibrium.  
2.5 Ion release assay 
 To measure the solubility degree of the scaffolds, they were placed on 12-well 
transwells  plates in contact with Dulbecco's Modified Eagle's medium with 10% fetal 
bovine serum and 1% penicillin-streptomycin, under shaking conditions for 10 d. The 
medium was extracted every day to measure the ion content (Ca, P and Zn) by 
inductively coupled plasma/optical emission spectrometry (ICP/OES) using an 
OPTIMA 3300 DV Perkin Elmer device (Waltham, MA, USA). The concentration of 
each ion was determined in two different samples measured by triplicate.  
2.6 In vitro tests 
 Previously to the in vitro studies below, the scaffolds were sterilized using UV 
light for 60 min with periodical rotation of the sample.    
Human MSCs (hMSCs) were cultured in mesenchymal stem cell basal medium 
(MSCBM; Lonza, Walkersville, MD, USA). Cells were washed with phosphate 
buffered saline (PBS, pH 7.4) and then tripsinized with 5 mL of trypsin/0.25 % EDTA 
(Lonza). Cells were then centrifuged at 1200g for 7 min, and the resulting pellet was 
  
suspended in culture medium and added (100 µL) drop by drop onto each scaffold 
(15·10
4 
cells/scaffold) in a 24-well plate. Thereafter, 1.2 mL of MSCBM were added 
per well, and scaffolds were incubated at 37 ºC in 5% CO2 for different times. Some of 
the scaffolds were previously loaded with osteostatin (Bachem, Bubendorf, 
Switzerland) by soaking in 2.5 mL of 100 nM peptide in PBS and continuous stirring 
for 24 h at 4 ºC. Peptide uptake and release were determined by measuring absorbance 
at 280 nm of the saline solution at different times.  
2.6.1 Morphological studies by confocal laser scanning microscopy 
 Human MSCs attachment to the different tested scaffolds was studied by 
fluorescence microscopy. Each scaffold was rinsed twice in PBS and then fixed with 
4% p-formaldehyde in PBS at 37 ºC for 20 min. Then, the scaffolds were washed again 
in PBS, and permeabilized in 0.5% Triton X-100 at 4 ºC for 5 min. Thereafter, non-
specific binding was blocked with 1% bovine serum albumin (BSA) in PBS for 20 min 
at 37ºC. The samples were then incubated at 37ºC for 20 min with Atto 565-conjugated 
phalloidin (at 1:40 dilution; Molecular Probes, Thermo Fisher, Waltham, MA, USA), 
which stains actin filaments of the cell microskeleton. After washing with PBS, cell 
nuclei were stained with 3 M 4´-6-diamino-2´-phenylindole dihydrochloride (DAPI) in 
PBS (Molecular Probes). Fluorescence microscopy was analyzed with a confocal laser 
scanning microscope OLYMPUS FV1200 (OLYMPUS, Tokyo, Japan), using a 60X 
FLUOR water dipping lens (NA=1.0). Micrographs were obtained using software 3D 
Imaris to project a single 2D image -converted into a TIF file- from the multiple Z 
sections by using an algorithm displaying the maximum pixel value of each Z 1-µm 
slice. DAPI and Atto 565-phalloidin staining were shown in blue and red respectively, 
whereas the scaffold reflection was shown in green. 
2.6.2 Cell growth 
 Human MSC growth was determined after 5 and 7 d of cell culture by the 
Alamar Blue method (AbD Serotec, Oxford, UK), following manufacturer’s 
instructions. Cells grown onto the scaffolds, before (BL-GE, 4ZN-GE, 5ZN-GE) and 
after osteostatin load (BL-GE+OST, 4ZN-GE+OST, 5ZN-GE+OST), were exposed to 
10% Alamar Blue solution for 4 h. Then, fluorescence intensity was measured with 
excitation and emission wavelengths of 560 and 590 nm, respectively, by a BioTek 
Synergy 4 spectrometer (Winooski, VT, USA).  
  
2.6.3 Cell cytotoxicity 
 Measurement of LDH activity released from hMSCs cells onto the scaffolds was 
used as a cytotoxicity assay. It is based on the reduction of nicotinamide adenine 
dinucleotide (NAD) by LDH [25], and the resulting colored compound is measured 
spectrophotometrically at 340 nm every 60 s for 4 min. This assay was carried out at 
day 10 of cell seeding by using a commercial kit (Spinreact, La Vall D'en Bas, Spain). 
2.6.4 Real Time PCR 
 Total RNA was isolated from hMSCs seeded onto the scaffolds after 7 d of cell 
culture (Trizol, Invitrogen, Groningen, The Netherlands). Gene expression of two 
osteoblastic differentiation markers, alkaline phosphatase (ALP) and runt related 
transcription factor-2 (RUNX2) were analyzed by real time PCR using QuantStudio5 
equipment and a described protocol [24] (Applied Biosystems-Thermo Scientific, 
Foster City, CA, USA). TaqMan
MGB
 probes were obtained by Assay-by-Design
SM
 
(Applied Biosystems). mRNA copy numbers were calculated for each sample by using 
the cycle threshold (Ct) value, and glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) rRNA (a housekeeping gene) was amplified in parallel with the tested genes. 
The number of amplifications steps required to reach an arbitrary Ct was computed. The 
relative gene expression was represented by 2
−ΔΔCt
, where ΔΔCt = ΔCttarget gene – 
ΔCtGAPDH. The fold change for the treatment was defined as the relative expression 
compared with control GAPDH expression, calculated as 2
−ΔΔCt
, where ΔΔCt = 
ΔCtreatment − ΔCcontrol. 
2.7. Statistical Analysis 
 Results are expressed as mean ± SEM (standard error of the mean). Statistical 
analysis was performed with nonparametric Kruskal-Wallis test and post-hoc Dunn´s 
test. A value of p < 0.05 was considered significant. 
3. Results and discussion 
3.1. Synthesis and shaping of 3D MBG scaffolds by rapid prototyping technique  
 Mesoporous materials of the ternary SiO2CaOP2O5 system were easily 
prepared in alcoholic medium under acidic conditions by using a non-ionic surfactant 
Pluronic
®
 P123 as structure-directing agent and the EISA method, as described above. 
  
TEOS, TEP, calcium nitrate tetrahydrate and zinc nitrate hexahydrate were used as 
SiO2, P2O5, CaO and ZnO sources, respectively (Table 1). As described in detail in 
section 2.2, MBG scaffolds were obtained by rapid prototyping, using a previous 
computer-aided design format by injecting a paste with a robotic injector [25]. TGA of 
the composite PCL-MBG scaffolds revealed ca 40 wt-% of PCL mixed with MBGs.  
 Gelatin is a natural polymer that is very hydrophilic and highly degradable in 
aqueous medium. However, after being crosslinked with GA, gelatin decreases the latter 
degradability [26,27]. In the present study, gelatin was chosen as toughening polymer as 
it is a hydrolyzed form of collagen, which is a major constituent of the extracellular 
matrix of most tissues [28], a biocompatible and low antigenicity protein, and shows 
high bioabsorptivity in vivo [29,30]. Scaffolds were coated by immersion in 2.4 % 
gelatin crosslinked with GA (0.05 w/v%), giving rise to the following scaffolds: BL-
GE, 4ZN-GE and 5ZN-GE, respectively.  
3.2 Characterization of raw MBGs and zinc-enriched MBGs  
Nitrogen adsorption–desorption isotherm and pore size distribution of BL, 4ZN 
and 5ZN MBGs, coated or not with GA crosslinked gelatin and loaded or unloaded with 
osteostatin, are shown in Figure 1. All curves can be identified as type IV isotherms, 
typical of mesoporous materials. They show type H1 hysteresis loops in the mesopore 
range, characteristic of cylindrical pores opened at both ends; the corresponding pore 
size distributions are also shown (Fig. 1, bottom). No significant variations in shape of 
the isotherms were found associated with gelatin coating or osteostatin loading in the 
scaffolds. Table 2 collects the textural properties, namely surface area, pore diameter 
and pore volume of the scaffolds. In general; the higher values of the textural properties 
were observed in the calcined samples. BL-GE, 4ZN-GE and 5ZN-GE scaffolds 
presented a slight decrease of surface area and pore volume due to gelatin coating, but 
these textural features remained high enough to host osteostatin molecules. Additional 
decreases of the specific surface area and pore volume were detected in BL-GE+OST, 
4ZN-GE+OST and 5ZN-GE+OST scaffolds, confirming the efficacy of the peptide load 
into these scaffolds. It is also important to highlight that, when MBG was doped with 
increasing amounts of zinc, the mesoporous order decreased, losing its well-ordered 
mesoporosity. As a result, specific surface area and pore volume distribution decreased 
as the zinc content increased [25]. 
  
TGA was performed to determine the residual content of PCL from calcined 
scaffolds and the gelatin content in the coated ones (Table 2). The % weight of oxides in 
BL, 4ZN and 5ZN calcined scaffolds were determined by EDX analysis. The 
experimental values included in Table 2 fairly agree with the nominal ones that are also 
included between brackets.   
 Gelatin-coated MBG scaffolds were grinded and the resultant powders were 
characterized by SA-XRD. The presence of diffraction maxima in this region was 
indicative of mesoporous order (Figure 2A). However, differences between samples as a 
function of the ZnO content were observed. Thus, BL-GE displayed a sharp diffraction 
maximum at 2 in the region of 1.0–1.4º, assigned to the (10) reflection, along with a 
poorly resolved peaks around 2.0 that can be assigned to the (11) reflection. These 
maxima were indexed on the basis of an ordered two-dimensional (2D) hexagonal 
structure (plane group p6mm) [6,31]. The intensity of the (10) maximum decreased 
associated with an increased ZnO in the scaffolds, indicating a progressive deterioration 
of the mesoporous structure in both 4ZN-GE and 5ZN-GE scaffolds.  
 To study the effectiveness and homogeneity of the biopolymer coating, FTIR 
spectroscopy and TGA studies were carried out. FITR spectra of GA crosslinked gelatin 
coated and uncoated scaffolds were collected (Figure 2B and inset). Spectra of native 
MBG scaffolds showed intense absorption bands at 1040 and 470 cm
-1
 corresponding to 
the asymmetric bending vibration of the Si–O–Si bond, and a band at 800 cm
-1
 
attributed to symmetric stretching of the Si–O bond [32]. The GA crosslinked gelatin 
hydrogel presented –CH2– groups and –NH2– groups exhibiting bands between 3190 
and 3440 cm,
–1
 corresponding to C–H and N–H bonds. The stretching bands at 1600-
1700 cm
–1
 and 1500-1560 cm
–1
 were assigned to C=O (Amide I) and N-C=O (Amide II) 
bonds, respectively. The deformation band at 1460-1600 cm
-1 
was assigned to N–H, 
whereas 1510 and 1440 cm
–1
 bands correspond to COO
–
 bond [33, 34]. The C=N band 
at 1535 cm
-1
 corresponds to crosslinked bond gelatin and the rest of bands to carboxyl 
and amino groups of the hydrogel. The amount of GA crosslinked gelatin film in BL-
GE, 4ZN-GE and 5ZN-GE scaffolds was determined by TGA. The results revealed that 
the three types of MBG samples exhibited comparable gelatin contents, with weight 
losses of 6 ± 0.5% (Table 2). TEM studies of these MBG scaffolds confirmed the results 
obtained by XRD. Figure 3 shows TEM images corresponding to BL and 4ZN scaffolds 
obtained with the electron beam parallel to the mesoporous channels, indicating well-
  
ordered hexagonally arranged mesostructures. TEM image of 5ZN scaffolds correspond 
to worm-like mesoporous structure [35]. 
 SEM micrographs of the intact surface and taken after fracture of 4ZN and 4ZN-
GE scaffolds, with and without GA crosslinked gelatin, are shown in Figure 4. The 
perpendicular view to the surface shows two types of channels of 700-1000 m and 
1000-1500 m in diameter. Moreover, the designed architecture exhibited giant pores of 
around 400 m between two adjacent rods in the cross-sectional fracture images after 
the biopolymer coating. In the 4ZN-GE scaffolds, it was possible to appreciate the GA 
crosslinked gelatin layer on the surface of the material. Higher magnification 
micrographs of the same region showed interconnected macropores in the range of 1–10 
m, as determined by mercury porosimetry. EDX spectra of the powders obtained by 
grinding the scaffolds showed the presence of Si, Ca, P and Zn in both 4ZN and 4ZN-
GE samples (Fig. 4). Moreover, gelatin-containing scaffolds also showed the presence 
of C from the hydrogel. The SiO2, CaO, P2O5 and ZnO content of these MBGs obtained 
by EDX were in good agreement with the expected values.  
 Figure 5 exhibits the cumulative intrusion (A) and pore size distribution (B) 
obtained by mercury intrusion porosimetry of MBG powders, as well as of dried and 
rehydrated scaffolds. The dried BL-GE, 4ZN-GE and 5ZN-GE scaffolds were 
rehydrated after being soaked in water by 24 h, and then lyophilized in a freeze dryer 
LyoQuest Telstar (Tarrasa, Spain). This processing allowed us to forecast the effect of 
gelatin on the porosity of the scaffolds under in vitro and in vivo conditions. In fact, 
gelatin hydrogel swelling in aqueous media is expected to impact the fluid exchange 
inside the scaffold, with paramount consequence for biological processes because of the 
improvement of the mechanical properties and the diffusion processes. Mercury 
porosimetry measurements allowed us to determine how the scaffold porosity increased 
as a consequence of hydration. In this way, from the cumulative intrusion curves of 
Figure 5A, total porosity values were obtained: 38, 30 and 34 %, for freeze-dried BL-
GE, 4ZN-GE and 5ZN-GE, respectively, which increased to 57, 51 and 42%, 
respectively, in the rehydrated scaffolds. This porosity increase took place mainly in the 
15–600 µm pore range: 8% for BL-GE, 18% for 4ZN-GE and 10% for 5ZN-GE (Figure 
5B). Thus, the gelatin coating should contribute to a better cell colonization. 
  
29
Si (Figure 6A) and 
31
P (Figure 6B) solid state MAS NMR was carried out for 








 represent the silicon atoms (denoted Si*) in (NBO)2Si*–(OSi)2, 
(NBO)Si*–(OSi)3, and Si*(OSi)4 (NBO = nonbonding oxygen), respectively. Table 3 





P NMR spectroscopy of each MBG composition. The signals 















 species with a network connectivity of 3.62. These data are consistent with 
previous studies using similar MBG scaffolds [25]. The main ZnO structure in 4ZN-GE 
scaffolds is present as [ZnO4] tetrahedra. These tetrahedra present a negative charge (2–




 ions acting as network compensators of 
charge and not as network modifier cations. Accordingly, the number of NBO decreases 
with the increase in the % of Q
4




(Figure 6A and 
Table 3).  
 It is important to note that MBG scaffolds, exhibiting higher Q
3
 % and smaller Q
2
 
% than MBG disks, were submitted to two calcinations at 700 ºC, while MBG disks 
were only subjected to one calcination [24]. This network distribution should influence 
the in vitro behavior of the scaffolds compared to the disks. Moreover, the network 
connectivity of 4ZN-GE and 5ZN-GE scaffolds slightly increased until reach values 
similar to BL-GE scaffolds (Table 3). It contrasts with the network connectivity 
decrease, previously observed in 7% ZnO MBGs [25]. Tetrahedral symmetry of the Q
4
 
units in BL scaffolds respect to Zn-enriched scaffolds showed a more isotropic structure 
evidenced by the increase of the full width at half maximum (fwhm) parameter (See 




 was found to be slightly greater 





 represent phosphorus atoms (denoted P*) in the PO4
3- 
species, 
(NBO)3P*–(OP), (NBO)2–P*–(OP)2 (NBO denotes a nonbonding oxygen, relative to 
another P atom), respectively [24]. In Figure 6B, the single-pulse 
31
P MAS NMR 
spectra of the tested materials showed a maximum at ∼2 ppm assigned to the Q0 
environment typical of amorphous orthophosphate. In addition to this signal from the 
main orthophosphate component, a minor 
31
P resonance was found to be present in all 
spectra. The latter signal was shown to shift from –8.0 ppm to –8.7 ppm with increasing 
ZnO% in MBGs. This resonance falls in the range of Q
1
 tetrahedra and can be assigned 
to P–O–Si environment, as previously reported [34,35]. It is interesting to highlight that 
  
ZnO introduction progressively causes a sightly decrease of Q
1
 units percentage but a 
chemical shift increase in 4ZN and 5ZN scaffolds. This suggests a partial conversion of 
P–O–Si units into P–O–Zn units. P–O–Zn formation has previously been detected by 
Vallet-Regí et al. in other bioactive MBGs with analogous composition [24,25,38].   
Changes in Ca
2+
, P(V) and Zn
2+
 ions released by the scaffolds, were measured soaking 
the scaffolds in MSCBM (Figure 7). For all the scaffolds, Ca
2+ 
and P(V) ion 
concentrations in medium underwent a sustained increase with time. For BL-GE 
scaffolds, the low concentration of Ca
2+
 ions in the medium was attributed to its high in 
vitro bioactive behaviour. Thus, a part of the Ca
2+
 ions released would precipitate as 
carbonate hydroxyapatite (CHA) on the scaffold surface being removed from the 
solution. In contrast, 4ZN-GE and 5ZN-GE scaffolds displayed slower bioactive 
response and, consequently, most part of the released Ca
2+
 ions from these scaffolds 
remained in the liquid medium. Regarding phosphorous ions, 4ZN-GE and 5ZN-GE 
scaffolds showed lower concentration in the medium because of the precipitation of 
calcium and zinc phosphate [25,35]. In contrast, Zn
2+
 release rate from these scaffolds 
was almost constant (about 1 ppm per day) during the first 5 d of soaking, but somewhat 
higher for 5ZN-GE compared to 4ZN-GE due to its higher ZnO content.  
 These results confirmed the medium accessibility to the inner part of the gelatin 





 ions release, compared with the uncoated scaffolds [25]. This is due to 
hydration, occurring after GA cross-linked gelatin scaffold swelling. In an aqueous 
environment, hydrogel allows water exchange and, subsequently, ion release increases. 
No different behaviour regarding the ion release profile was observed in the osteostatin-
loaded scaffolds (data not shown). Of note, Zn
2+
 released from 4ZN-GE and 5ZN-GE 
scaffolds was larger than that of 4ZN and 5ZN as dense disks of the same composition 
as the scaffolds [24]. This could be explained because of the high network connectivity 
of these dense glasses; Zn
2+
 ions seem to mainly behave as network formers, more 
difficult to release to the surrounding medium. Moreover, the open interconnected 
macroporosity and the gelatin coating of the scaffolds facilitate ions release, compared 
to the disks. This makes the scaffolds an improved material for biological applications.  
3.3 Rehydration effect of the porous scaffolds 
 The polar groups of gelatin make it a hydrophilic and absorbent polymer 
[37,38]. To investigate the behavior of gelatin-coated MBG scaffolds in body fluids, 
  
rehydration assays were carried out. Figure 8A illustrates the swelling ratio of the 
different scaffolds along time; the %W curves show a fast increase of water absorption 
in the first 15 min, followed by a slight increment during the following 24 h. BL-GE, 
4ZN-GE and 5ZN-GE scaffolds absorb between 120-140 wt-% of water by respect to 
their initial dry mass. This high grade of hydration could be explained by the presence 
of 6-7 wt. % GA crosslinked gelatin in the scaffolds (Table 2) combined with their high 
interconnected macroporosity (Figures 4 and 5). The swelling capability and pore size 
enlargement displayed by all the scaffolds was similar due to their alike macropore size 
distribution and pores interconnectivity [39,40].  
3.4 Osteostatin loading and release in MBG scaffolds 
 We found that the mean retention of osteostatin by the tested scaffolds after 24 h 
of loading was: 47 % (BL-GE+OST), 52 % (4ZN-GE+OST) and 52% (5ZN-GE+OST), 
equivalent to 0.52, 0.71 or 0.62 μg osteostatin/g scaffold, respectively. These loaded 
materials released (mean): 56 % (BL-GE+OST), 52% (4ZN-GE+OST) or 59% (5ZN-
GE+OST) of loaded peptide to the surrounding medium within 1 h; 90% (BL-
GE+OST), 87% (4ZN-GE+OST) and 90% (5ZN-GE+OST) at 24 h; and virtually 100 % 
in all these scaffolds at 96 h (Figure 8B). This indicates that minimal osteostatin 
retention occurs in these biomaterials. Osteostatin uptake by MBG scaffolds was of the 
same magnitude order in μg/g than previously observed in MBG disks [22,24]. 
However, for the reasons that will be given later was somewhat higher in the scaffolds. 
Interestingly in this regard, our group previously demonstrated that this peptide, at 
concentrations in the sub-nM range, was efficient to increase osteoblast function in vitro 
[23,41,42]. The release mechanism of osteostatin is assumed to be diffusion through the 
mesopores [43]. Therefore, that silica matrix is insoluble at pH 7.4, the release of this 
peptide to the surrounding solution could be described by a deviation from the 
theoretical first-order behaviour in the Noyes–Whitney equation with the introduction 
of an empirical non-ideally factor  [44,45]:  
wt/w0 = A(1-exp k1·t)
 
                    
 Wt stands for the peptide mass released at time t; w0 represents the maximum 
initial mass of the peptide inside the pores; A is the maximum amount of peptide 
released; and k1 is the release rate constant, which is independent of peptide 
concentration and gives information about the solvent accessibility and the diffusion 
  
coefficient through mesoporous channels. The peptide release profiles showed a 
deviation from the theoretical first-order behaviour described by the equation above 
(Figure 8B): faster release within 24 h, reaching a stationary phase after 48 h. This 
deviation could be due to several factors, such as the volume of the peptide, the 
distortion of the mesopore channels and/or the release of peptide molecules adsorbed on 
the external surface of the scaffold matrices. Values for δ range between 1, for materials 
that follows first-order kinetics, and 0 for those rapidly releasing the load located at pore 
entrances. Table 4 shows the release parameters by plotting our data using this semi-
empirical first-order model. According to this model,  gives an idea of the accuracy of 
this approximation. This parameter was found to be similar for all the scaffolds studied, 
indicating that osteostatin molecules are released from the internal and external surface 
of the mesopore structure of each loaded glass (Table 4). It is worth noticing that 
peptide load (µg/g) is somewhat higher in MBG scaffolds than in analogous MBG disks 
[24], due to more accessible mesopore structure by their hierarchical channels and 
macroporosity.  
3.5 In vitro cytocompatibility assays 
3.5.1 Cell morphological studies by confocal laser scanning microscopy and cell 
growth 
 3D confocal microscopy studies were carried out on the cylindrical scaffolds 
studied after hMSCs seeding (Figure 9A).  The geometrical center of each scaffold (6 
x10 mm
2
) was scanned to determine the cell morphology after 5 d, using Atto 565–
phalloidin as fluorescence probe of F-actin microfilaments. In this case, DAPI 
fluorostaining was not used because it also dyes the gelatin coating of the scaffolds. 
Actin is the most important interconnected filament protein in the cytoskeleton, 
performing critical cell functions, including cell shape maintenance, cell movement as 
well as intracellular trafficking [46]. We found that hMSCs presented their typical 
spindle-shaped morphology and were adequately spread on the scaffold surface, 
indicating the biocompatibility of every type of scaffolds tested. Furthermore, cell 
clusters interconnected at different depths in the scaffold were also observed as 
evidence of optimal internalization and intercellular communication in the 4ZN-GE 
scaffolds.  
  
 We next studied and compared the osteogenic activity conferred by zinc and 
osteostatin to these scaffolds as carriers of hMSCs. Human MSC growth was increased 
in zinc-containing scaffolds, compared to BL scaffolds, at 5 and 7 d; and this positive 
effect was significantly higher in 4ZN-GE and 5ZN-GE materials loaded with 
osteostatin (BL-GE+OST, 4ZN-GE+OST and 5ZN-GE+OST) at both time periods 
(Figure 9B), indicating the synergistic effect between both factors in this context. 
Consistent with this finding, hMSC growth and spreading occurred on both the surface 
and inside of the zinc-enriched and native MBG scaffolds with osteostatin load (Figure 
9A).  
3.5.2 Cytotoxicity assay: Lactate dehydrogenase (LDH) activity 
 None of the tested materials induced significant cell death assessed by cell LDH 
release; but 5ZN-GE scaffolds exhibited a (not significant) tendency to increase LDH 
levels, which was counteracted by osteostatin in this type of scaffold at day 10 of cell 
culture (Figure 10). This would be due to a higher degradation of 5ZN-GE scaffold 
compared to the other scaffolds studied, and it might account for the lower cell growth 
observed in this scaffold at 5 and 7 d. Lozano et al. [23] previously demonstrated in 
vitro that exposure of the pre-osteoblast MC3T3-E1 cell line to osteostatin-loaded 
ordered mesoporous SBA-15 disks stimulated cell growth and osteoblastic 
differentiation. Subsequent studies showed that SBA-15 based ceramics containing 
osteostatin as implants are biocompatible and induce recruitment and activation of 
osteoprogenitors to promote bone regeneration in osteoporotic rabbits [31]. Previous 
studies also have shown that 5% appears to be the maximum amount of ZnO to be 
incorporated into certain types of bioactive glasses causing no cytotoxicity while 
enhancing osteoblast cell growth [4749]. In the same line, Vallet-Regí’s group recently 
demonstrated that MBGs doped with 7% ZnO were cytotoxic for MC3T3-E1 cells [25]. 
3.5.3 Cell differentiation: RUNX2 and ALP gene expression 
  We next evaluated the capacity of these scaffolds, loaded or not with osteostatin, 
to affect hMSC differentiation by evaluating the gene expression of two osteoblast 
differentiation markers, RUNX2 and ALP. RUNX2 is an early osteogenic 
differentiation marker that directs cell progenitors toward the osteoblastic lineage [50]. 
We found that both 4ZN-GE and 5ZN-GE scaffolds were inefficient to affect RUNX2 
gene expression in hMSCs cultures at day 7, but the simultaneous presence of 
  
osteostatin in these scaffolds increased this expression at this time (Figure 11A). ALP is 
considered as a potential key biochemical marker of osteogenic differentiation, which 
acts to cleave phosphate groups from different substrates during osteogenesis [51]. 
Here, we found that 4ZN-GE+Ost and 5ZN-GE+Ost scaffolds significantly increased 
the gene expression of ALP at day 7 of hMSC culture, compared to osteostatin-
unloaded scaffolds (Figure 11B).  
It has previously been suggested that the putative benefits of adding Zn
2+
 to a 
bioactive glass would be impaired by Zn
2+
-promoted material degradation. In fact, no 
clear data have been presented to date to confirm the osteogenic effect of zinc 
decorating bioactive silicate glasses [52,53]. In our recent studies [24], osteostatin load 
was found to confer zinc-enriched MBG disks the ability to stimulate ALP activity and 
matrix mineralization in cultured MC3T3-E1 cells in an osteoblast differentiation 
medium. In the present research using hMSCs, the combination of zinc and osteostatin 
into 4ZN-GE+OST and 5ZN-GE+OST scaffolds significantly increased cell growth and 
thorough cell colonization of these materials compared to BL-GE scaffolds. 
Furthermore, zinc and osteostatin, in conjunction but not independently, were shown to 
induce the gene expression of the osteoblastic differentiation markers RUNX2 and ALP 
in hMSCs in the absence of a promoting differentiation medium (Figure 11).  
3.6 Synergistic effect of zinc and osteostatin on hMSC growth and osteogenic 
differentiation 
The underlying mechanism of the observed synergistic effect of zinc and 
osteostatin on hMSC growth and osteogenic differentiation is unknown at present.  Zinc 
has important roles in cell signal transduction and gene expression, and as a catalytic 
component of a variety of mammalian enzymes; however, its putative effects on MSCs 
have been poorly investigated [54]. A previous study, using sol-gel bioactive glass 
granules containing 2-5% zinc has shown a stimulatory effect of this cation on 
osteogenic differentiation -based on ALP activity- of adult rat MSCs [55].  
On the other hand, another study reported that zinc ions, at sub or supra nM 
concentrations, inhibited osteogenic differentiation of mouse MSCs [56]. Moreover, 
another report has shown that ZnT7, a member of the zinc transporter family SLC30A, 
can act as an inhibitor during dexamethasone-induced differentiation of rat MSCs; an 
effect which appears to be dependent in part on targeting extracellular signal-regulated 
kinase (ERK) signaling pathway [57]. In addition, a variety of in vitro and in vivo 
  
studies demonstrate the osteogenic effects of osteostatin [20,21,58]. Of note, one of 
these studies has reported that osteostatin synergistically interacts with Si-HA-coupled 
fibroblast growth factor-2 to induce ALP and matrix mineralization in MC3T3-E1 and 
primary human osteoblastic cells by an ERK-dependent mechanism [59]. A possible 
interaction between Zn ions and osteostatin through ERK activation, or any alternative 
intracellular mechanism(s), to improve the osteogenic efficacy of our scaffolds is an 
attractive hypothesis that deserves further studies. 
The osteoblastic lineage is known to be regulated by various molecules 
including systemic and local peptide factors. As in other tissues, in which peptides can 
act as cell mediators, cell surface peptidases can modulate their activity. In this regard, 
zinc-metallopeptidase neprilysin, a cell surface peptidase present in all the cells of the 
osteoblastic lineage (preosteoblasts, mature osteoblasts and osteocytes) [60,61], is 
upregulated in hMSCs during osteogenic differentiation [62]. Also of interest, this zinc-
metallopeptidase can cleave several osteogenic peptides, including native PTHrP 107-
139 (containing the osteostatin sequence 107-111). In this scenario, it could be 
speculated that endogenous PTHrP, which increases with osteoblast differentiation 
[17,18], might collaborate with Zn
2+
 to promote such differentiation. Although further 
studies are waiting to confirm this hypothesis, the synergistic effect observed with our 
zinc-containing MBG scaffolds after priming with osteostatin in the present context 
supports this rationale.  
 In any event, in the present study, we provide the first evidence that the 
combination of zinc and osteostatin in MBG scaffolds can promote cell proliferation 
and differentiation of hMSCs without classical differentiation inductors, suggesting the 
potential of this approach in bone tissue engineering applications.  
4. Conclusions 
This study reports the synthesis and design, using a rapid prototyping technique, of 
meso-macroporous MBG 3D-scaffolds coated with GA-crosslinked gelatin, and 
enriched with zinc and osteostatin. These 3-D hierarchical interconnected macroporous 
scaffolds show excellent cellular internalization and an outstanding hMSCs response in 
terms of cell adhesion, growth and osteogenic differentiation. The composition and 3D-
architecture of GA crosslinked gelatin coating the hierarchical porous of MBG scaffolds 
facilitate the controlled release of both zinc and osteostatin, which positively affects 
hMSCs development and their osteogenic differentiation in medium without classical 
  
differentiation inductors. This system allowed us to disclose, for the first time, a 
synergistic effect of zinc and osteostatin to enhance hMSC cell growth and osteogenic 
differentiation, suggesting its potential use in bone tissue engineering applications. 
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Figure 1. N2 adsorption-desorption isotherms and the corresponding pore size 
distributions of the scaffolds before and after being coated with gelatin (GE) and before 
and after being loaded with osteostatin (OST). 
Figure 2. DRX patterns (A) and FITR spectra (B) of BL and zinc-doped scaffolds (4ZN 
and 5ZN) before and after being coated with GA crosslinked gelatin. *A magnification 
of (B).  
Figure 3. TEM images of BL, 4ZN and 5ZN showing the first two a 2D hexagonal 
mesoporous structure and the last one a worm-like mesoporous structure.  
Figure 4. SEM images of fracture and surface of 4ZN and 4ZN-GE scaffolds. At the 
bottom, the corresponding EDX spectra. 
Figure 5. (A) Cumulative Hg intrusion volume as a function of the pore diameter. (B) 
Pore size distribution of BL-GE, 4ZN-GE and 5ZN-GE powders (P-), dried and 
rehydrated scaffolds (H-). 
Figure 6. Solid-state (A) 
29
Si and (B) 
31
P single-pulse MAS-NMR spectra of BL-
GE, 4ZN-GE and 5ZN-GE scaffolds. Q
n
 unit areas were calculated by Gaussian 
line-shape deconvolution and displayed in green.  
Figure 7. Evolution with time of the ionic concentration of calcium, phosphorus and 
zinc after soaking BL-GE, 4ZN-GE and 5ZN-GE scaffolds between 6 h and 10 days in 
complete medium.  
Figure 8. (A) Swelling ratio (%W) of BL-GE, 4ZN-GE and 5ZN-GE scaffolds as a 
function of incubation time. (B) Osteostatin release from MBGs scaffolds between 1 h 
and 4 days in PBS. Points to trace the curves are the means of three independent 
measurements per time period. SEM values (representing a coefficient of variation of 
<5% for each point) are omitted for simplification. 
Figure 9. (A) hMSCs cultured onto the BL-GE+OST, 4ZN-GE+OST and 5ZN-
GE+OST scaffolds, by 5 days, were observed with confocal laser scanning microscopy. 
Atto 565–phalloidin was used as fluorescence probes to determine the cell morphology, 
Atto 565–phalloidin staining the F-actin microfilaments to visualize the cytoskeleton 
  
indicating cell viability. Blue autofluorescence of the gelatin/MBG is also evident. The 
reflection of the scaffold material was visualized in green. (For interpretation of the 
references to colour in this figure legend, the reader is referred to the web version of this 
article). (B) Proliferation of MC3T3-E1 preosteblast-like cells as a function of culture 
time onto BL, 4ZN and 5ZN scaffolds with and without osteostatin at 5 d and 7 d.  
Figure 10. LDH of hMSCs in the presence of BL-GE, 4ZN-GE and 5ZN-GE scaffolds 
loaded or not with osteostatin after 10 days of cell culture. Results are means ± SEM of 
three measurements in triplicate.  
Figure 11. Runx2 (A) and ALP (B) mRNA levels (measured by real-time PCR) in 
hMSCs in the presence of BL-GE, 4ZN-GE and 5ZN-GE scaffolds loaded or not 
osteostatin at 7 d (C and D) and 12 d (E) of culture. Results are mean ± SE (n = 5). *p < 


















































BL 4.5 67.5 1.12 8.90 0.71 1.10 --- 
4ZN 4.5 67.5 1.12 8.90 0.71 1.10 0.60 




Table 2. Textural properties of the scaffolds being SBET the BET surface, VP pore volume and DP 
pore diameter. The percentage of PCL and gelatin contents in the scaffolds were determined 
by TGA. The weight percentages of Si, P, Ca and Zn in the scaffolds were determined by EDX. 
The nominal values are in brackets. Standard error of mean values (representing a coefficient 












Atomic Composition %  
(EDX) 
Si P Ca Zn 











BL-GE 188 0.21 3.7 -- 7 -- -- -- -- 
BL-OST 164 0.17 3.5 -- -- -- -- -- -- 












4ZN-GE 151 0.14 3.5 -- 6 -- -- -- -- 
4ZN-OST 113 0.10 3.5 -- -- -- -- -- -- 












5ZN-GE 136 0.14 3.5 -- 6 -- -- -- -- 
5ZN-OST 101 0.10 3.5 -- -- -- -- -- -- 




Table 3. Chemical shifts and relative peak areas obtained by solid state 29Si and 31P Single Pulse MAS NMR 
spectroscopy. The peaks areas for the Qn units were calculated by Gaussian line-shape deconvolutions and their 
relative populations were expressed as percentages (%).  
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BL-GE -112 63.3 8.9  -102 33.8 6.8  -92 3.0 6.0  3.60  2.4 90 5.3  8.0 10.0 8.0 
4ZN-GE -111 67.4 10  -102 28.7 5.0  -92 3.8 8.3  3.63  2.6 95 5.7  8.2 5.0 7.3 
5ZN-GE -111 69.4 9.6  -102 23.7 6.4  -93 6.9 7.6  3.62  2.6 96 5.5  8.7 4.0 7.2 
a













Table 4. Kinetic parameters of the osteostatin release from BL-GE, 4ZN-GE and 5ZN-GE 
scaffolds. w0: initial mass loaded (g OST/g MBG); (wt/w0)max: maximum amount of the relative 









BL-GE 56 96.2 ± 3.4 40.9 ± 2 0.48 ± 0.02 0.996 
4ZN-GE 52 98.2 ± 3.1 37.2 ± 1 0.50 ± 0.03 0.998 




Statement of significance 
Mesoporous bioactive glasses (MBGs) are bioceramics whose unique properties make 
them excellent materials for bone tissue engineering. Physico-chemical characterization 
of MBGs as scaffolds made by rapid prototyping, then doped with zinc (potential 
osteogenic, angiogenic and bactericidal ion) and loaded with osteostatin (osteogenic 
peptide) are described. These Zn-MBGs scaffolds showed 3D hierarchical meso-
macroporous structure that enables to host and release osteostatin. When decorated with 
human mesenchymal stem cells (hMSCs), MBGs scaffolds enriched with both zinc and 
osteostatin exhibited a synergetic effect to enhance hMSC growth, and also their 
osteogenic differentiation without addition of classical osteoblastic differentiation 
factors to the culture medium. This novel strategy has a great potential for use in bone 
tissue engineering. 
 
 
